Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Johnson

Showing results (291-300 of 376) with videos related to

Pageof 38
Sort By:
Investigational New Drugs|April 9, 2001
A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with advanced non-small cell cancer previously treated with chemotherapyJ E Dowell, D H Johnson, J S Rogers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987
High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancerD H Johnson, M J DeLeo, K R Hande, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancerA F List, J D Hainsworth, B W Davis, et al.
The American Journal of Medicine|December 1, 1986
Acute nonlymphocytic leukemia after treatment of small cell lung cancerD H Johnson, L L Porter, A F List, et al.
Seminars in Radiation Oncology|April 21, 1999
Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancerC D Blanke, H Choy, M Teng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1987
A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: a phase III trial of the Southeastern Cancer Study GroupD H Johnson, L H Einhorn, R Birch, et al.
Cancer|June 8, 2001
Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trialP J Loehrer, M Jiroutek, S Aisner, et al.
Human Gene Therapy|December 19, 2001
Genetic modification of human trabecular meshwork with lentiviral vectorsN Loewen, M P Fautsch, M Peretz, et al.
The British Journal of Ophthalmology|December 25, 2010
Transretinal degeneration in ageing human retina: a multiphoton microscopy analysisY Lei, N Garrahan, B Hermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot studyA C Wolff, D S Ettinger, D Neuberg, et al.
Pageof 38

Showing results (291-300 of 376) with videos related to

Sort By:
Pageof 38
Investigational New Drugs|April 9, 2001
A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with advanced non-small cell cancer previously treated with chemotherapyJ E Dowell, D H Johnson, J S Rogers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987
High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancerD H Johnson, M J DeLeo, K R Hande, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancerA F List, J D Hainsworth, B W Davis, et al.
The American Journal of Medicine|December 1, 1986
Acute nonlymphocytic leukemia after treatment of small cell lung cancerD H Johnson, L L Porter, A F List, et al.
Seminars in Radiation Oncology|April 21, 1999
Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancerC D Blanke, H Choy, M Teng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1987
A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: a phase III trial of the Southeastern Cancer Study GroupD H Johnson, L H Einhorn, R Birch, et al.
Cancer|June 8, 2001
Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trialP J Loehrer, M Jiroutek, S Aisner, et al.
Human Gene Therapy|December 19, 2001
Genetic modification of human trabecular meshwork with lentiviral vectorsN Loewen, M P Fautsch, M Peretz, et al.
The British Journal of Ophthalmology|December 25, 2010
Transretinal degeneration in ageing human retina: a multiphoton microscopy analysisY Lei, N Garrahan, B Hermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot studyA C Wolff, D S Ettinger, D Neuberg, et al.
Pageof 38